9894EGP
- Active ingredient
- upadacitinib
- Strength
- 15 mg
- Form
- tablet
- Manufacturer
- eva pharma
- Route
- oral.solid
Uses
Used for rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, and other approved inflammatory disorders.
Do not use if
Contraindicated in patients with known hypersensitivity to upadacitinib or its excipients.
Side effects
May cause upper respiratory infections, acne, nausea, elevated liver enzymes, and increased lipid levels.
Warnings
Associated with serious infections, malignancy, cardiovascular events, and thrombosis. Careful monitoring is required.
How it works
A Janus kinase (JAK) inhibitor that reduces inflammatory signaling pathways.
Storage
Store at room temperature in the original package.
